Novartis AG - Company Profile
Powered by
All the data and insights you need on Novartis AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Novartis AG Strategy Report
- Understand Novartis AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Novartis AG’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
30 Sep 2022 | Inter-American Investment (IDB Invest) Prices USD66.75 Million in Private Placement of 4.55% Social Bonds due 2032 | Debt Offering |
Meiji Yasuda Life Insurance Co
|
Inter American Investment Corp
|
27 Sep 2022 | Jiuzhou Pharmaceutical to Acquire Sandoz for USD25.8 Million | Acquisition |
Zhejiang Jiuzhou Pharmaceutical Co Ltd
|
Sandoz (China) Pharmaceutical Co Ltd
|
01 Sep 2022 | Novartis Enters Packaging Agreement with Siegfried Holding for Atectura | Contract Service Agreement |
Novartis AG
|
Siegfried Holding AG |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer